Deciphex Raises $11.5M in Series B Funding Led by ACT Venture Capital
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Surgical training: “With the ‘PROFICIENCY’ project, we want to advance simulator-based continuing education in surgery,” explains Prof. Bruno Schmied, M.D., Chief of Surgery at the Cantonal Hospital of St. Gallen.
Ultrahuman, a leading metabolic fitness platform that uses glucose biomarkers to help people optimize their lifestyle.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330